Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Marie Suzanne Westberg has worked on the following 13 EPO patent applications which have been published in the last five years:

EP10785056

POLYMORPHOUS FORMS III AND IV OF N-BENZOYL STAUROSPORINE

IPC classification:
C07D 498/22
Applicant:
Novartis AG
Agent:
Marie Suzanne Westberg, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11751752

TREATMENT OF HYPERTENSION AND/OR PREVENTION OR TREATMENT OF HEART FAILURE IN A MAMMAL RECEIVING ANTI-COAGULANT THERAPY

IPC classification:
A61K 31/221, A61K 31/41, A61P 9/00, A61P 9/04, A61P 9/12
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Agent:
Karen Dorothee Larbig, Novartis Pharma GmbH
Status:
EXAMINATION IN PROGRESS
EP14167842

Treating dyspnea associated with acute heart failure with H2 relaxin

IPC classification:
A61K 38/22, A61P 9/04, C07K 14/64
Agent:
Marie Suzanne Westberg, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP14191582

Treatment of familial Mediterranean Fever with anti IL-1b antibodies

IPC classification:
A61K 39/395, A61P 19/02, A61P 37/00, C07K 16/24
Applicant:
Novartis AG
Agent:
Marie Suzanne Westberg, Novartis Pharma AG
Status:
GRANT OF PATENT INTENDED
EP13745552

TREATING INFLAMMATION USING SERELAXIN

IPC classification:
A61K 38/00
Applicant:
Novartis AG
Agent:
Marie Suzanne Westberg, Novartis Pharma AG
Status:
GRANT OF PATENT INTENDED
EP13798486

USE OF IL-1 BETA BINDING ANTIBODIES FOR TREATING PERIPHERAL ARTERIAL DISEASE

IPC classification:
A61K 39/395, A61P 9/00, A61P 29/00, C07K 16/24
Applicant:
Novartis AG
Agent:
Marie Suzanne Westberg, Novartis AG
Status:
EXAMINATION IN PROGRESS
EP11709841

MODULATING AQUAPORINS WITH RELAXIN

IPC classification:
A61K 38/22, A61P 7/10, A61P 7/12, A61P 15/04
Applicant:
University of Florida Research Foundation, Inc.
Applicant:
University of Melbourne
Agent:
Marie Suzanne Westberg, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11758422

NEW PROCESS FOR THE PREPARATION OF INTERMEDIATES USEFUL FOR THE MANUFACTURE OF NEP INHIBITORS

IPC classification:
C07C 227/18, C07C 227/20, C07C 227/22, C07C 229/30, C07C 229/34, C07C 231/10, C07C 269/06, C07C 271/22, C07D 207/24, C07D 207/267, C07D 207/27, C07D 207/277, C07D 207/33, C07D 207/38
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Agent:
Karen Dorothee Larbig, Novartis Pharma GmbH
Status:
PATENT GRANTED
EP16162699

ANTIBODY FORMULATION

IPC classification:
A61K 39/395, C07K 16/24
Applicant:
Novartis AG
Agent:
Marie Suzanne Westberg, Novartis AG
Status:
EXAMINATION REQUESTED
EP11758421

PROCESS FOR THE PREPARATION OF INTERMEDIATES FOR THE MANUFACTURE OF NEP INHIBITORS

IPC classification:
C07C 269/06, C07C 271/22
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Agent:
Karen Dorothee Larbig, Novartis Pharma GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15717969

METHODS OF SELECTIVELY TREATING ASTHMA USING IL-13 ANTAGONISTS

IPC classification:
C12Q 1/68
Applicant:
Novartis AG
Agent:
Marie Suzanne Westberg, Novartis AG
Status:
EXAMINATION REQUESTED
EP16174665

METHOD OF TREATING CHRONIC HEART FAILURE

IPC classification:
A61K 38/22, A61P 9/04, C07K 14/64
Agent:
Marie Suzanne Westberg, Novartis AG
Status:
APPLICATION PUBLISHED
EP15730858

USE OF SERELAXIN TO REDUCE GDF-15

IPC classification:
A61B 5/00, A61K 38/00, A61K 38/22, A61P 9/00, A61P 11/00
Applicant:
Novartis AG
Agent:
Marie Suzanne Westberg, Novartis Pharma AG
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature